Evaluating multiplicity reporting in analgesic clinical trials: An analytical review

Maaz S Khan1,2, Lori F Zarmer2, Jie Liang3

  • 1Banner University Medical Center-Tucson, Tucson, Arizona, USA.

Abstract

Insights

Many analgesic trials use multiple comparisons, increasing false positive risks. Reporting of multiplicity corrections remains inadequate, highlighting a need for better statistical adjustment practices in pain research.

Area of Science:

  • Clinical Trials
  • Pain Research
  • Statistical Methodology

Background:

  • Analgesic trials frequently involve multiple comparisons, raising concerns about inflated false positive rates.
  • Despite advancements in statistical methods and regulatory guidance, the reporting of multiplicity corrections in recent analgesic randomized controlled trials (RCTs) is unclear.

Purpose of the Study:

  • To identify reporting inadequacies in multiple analysis adjustments and explanations within analgesic RCTs.
  • To understand current practices and deficiencies in multiplicity correction reporting.

Main Methods:

  • A systematic review of RCTs published in the European Journal of Pain, Journal of Pain, and PAIN between January 2018 and December 2022.
  • Data extraction focused on trial characteristics, presence of multiple comparisons, and methods used for multiplicity correction.

Main Results:

  • Of 112 analyzed articles, 48 had a pre-specified primary analysis plan.
  • Multiple analyses were present in 65 articles, with 60% applying adjustments, predominantly using the Bonferroni method.
  • No significant changes in multiplicity correction practices were observed compared to previous studies.

Conclusions:

  • A persistent reliance on multiple comparisons in analgesic trials exists without a corresponding increase in multiplicity corrections.
  • There is an urgent need for enhanced reporting and implementation of statistical adjustments to improve reproducibility in pain research.

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
513
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
773
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.6K
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
225
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.8K
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
324